Richard E Lowenthal sold $724K of ARS Pharmaceuticals (SPRY)

Executed Aug 21 2025, disclosed Aug 22 2025, 1 day later.

Value, as filed

$724K

50,000 sh × $14.49

Executed

Aug 21 2025

the trade date, as filed

Disclosed

Aug 22 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RL Richard E Lowenthal PRESIDENT AND CEO profile →

Richard E Lowenthal (PRESIDENT AND CEO) filed 5 Form 4 reports in the past 24 months (0 purchases, 5 sales), most often in SPRY. The largest single filing was $1.5M of SPRY (90,169 sh across 2 lots, as filed), executed Nov 12 2024.

The name

SPRY SPRY SPRY · 33 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Richard E Lowenthal in SPRY

SPRYSALE ARS Pharmaceuticals, Inc. $1.2M
100,000 sh across 2 lots
Exec Dec 17 2024
Filed Dec 19 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.3M
100,000 sh across 2 lots
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.4M
100,000 sh across 2 lots
Exec Nov 19 2024
Filed Nov 21 2024 · 5:30 PM ET SPRYSALE ARS Pharmaceuticals, Inc. $1.5M
90,169 sh across 2 lots
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET